33%

Faster Time to Insights

52%

Cost & Maintenance Savings

41%

Better Patient Decision-Making

67%

Increase in Sales Margins

This pharma market access analytics dashboard lets pharma executives, R&D professionals, and healthcare strategists compare long acting and short acting AED monotherapy on healthcare utilization, patient adherence, and cost. It supports drug strategy and market positioning decisions. Infocepts built it on MicroStrategy.

Infocepts builds the data layer for dashboards like this through data engineering and integration.

Explore more in the Life Sciences section, or see neurology treatment insights and SIB therapeutic sales insights.

Want market access analytics for your portfolio? Talk to our team.

Frequently asked questions

It compares drug options, such as long acting versus short acting AED monotherapy, on healthcare utilization, patient adherence, and cost efficiency, giving pharma executives evidence for market positioning decisions.

Up to 70% of epilepsy patients can achieve seizure control with the right medication, so comparing efficacy and adherence between drug formats directly affects both patient outcomes and which product a business prioritizes.

Pharma executives, R&D professionals, and healthcare strategists making decisions about drug positioning and market access strategy.

A drug that is more effective in trials but harder to adhere to in practice may perform worse in the real world; comparing both together avoids that blind spot.

Healthcare utilization and cost outcomes associated with each drug format, not just the drug’s list price, since downstream utilization often affects total cost more than acquisition cost.

By structuring utilization, adherence, and cost data into a BI platform through Business Analytics services, drawing on Life Sciences industry work.